<DOC>
	<DOCNO>NCT01997736</DOCNO>
	<brief_summary>The purpose study collect preliminary safety effectiveness data evaluate Toray Satake Balloon Thermal Ablation System ( TSB ) treat subject symptomatic paroxysmal atrial fibrillation resistant antiarrhythmic drug therapy .</brief_summary>
	<brief_title>Pilot Study Evaluating Toray Satake Balloon Thermal Ablation System Treatment Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Diagnosis recurrent symptomatic paroxysmal atrial fibrillation ≥2 Symptomatic atrial fibrillation episode At least 1 paroxysmal atrial fibrillation episode document ECG device record system 6 month prior enrollment AND At least 1 additional ( total ≥2 ) paroxysmal atrial fibrillation episode document ECG device record system , OR , minimum , physician 's note indicate recurrent symptomatic atrial fibrillation No episode &gt; 7 day Failed respond intolerant ≥1 Class I , II , III IV antiarrhythmic drug Able willing provide inform consent Health Insurance Privacy Portability Act ( HIPAA ) authorization Able willing meet study requirement , include attend postablation procedure assessments visit Left atrium ≥50 mm Chronically use amiodarone 3 month prior enrollment Previous leave atrial ablation surgical treatment atrial fibrillation Left ventricular ejection fraction ( LVEF ) &lt; 35 % New York Heart Association ( NYHA ) Class III IV heart failure History myocardial infarction ( MI ) unstable angina 6 month prior enrollment Multiple exclusion criterion establish overall good health likely study compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Paroxysmal Atrial Fibrillation</keyword>
	<keyword>Catheter Ablation</keyword>
	<keyword>Ablation Techniques</keyword>
</DOC>